Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

Subramanian J, Simon R.

J Natl Cancer Inst. 2010 Apr 7;102(7):464-74. doi: 10.1093/jnci/djq025. Epub 2010 Mar 16. Review.

2.

Re: Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

Boutros PC, Pintilie M, John T, Starmans MH, Der SD, Shepherd FA, Tsao MS, Jurisica I.

J Natl Cancer Inst. 2010 Nov 3;102(21):1677-8; author reply 1678-9. doi: 10.1093/jnci/djq385. Epub 2010 Oct 4. No abstract available.

PMID:
20921041
3.

Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.

Baty F, Facompré M, Kaiser S, Schumacher M, Pless M, Bubendorf L, Savic S, Marrer E, Budach W, Buess M, Kehren J, Tamm M, Brutsche MH.

Am J Respir Crit Care Med. 2010 Jan 15;181(2):181-8. doi: 10.1164/rccm.200812-1807OC. Epub 2009 Oct 15.

PMID:
19833826
4.

High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.

Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ, Yang HX.

Eur J Surg Oncol. 2012 Jun;38(6):523-30. doi: 10.1016/j.ejso.2012.02.180. Epub 2012 Mar 21.

PMID:
22440742
5.

Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.

Chen DT, Hsu YL, Fulp WJ, Coppola D, Haura EB, Yeatman TJ, Cress WD.

J Natl Cancer Inst. 2011 Dec 21;103(24):1859-70. doi: 10.1093/jnci/djr420. Epub 2011 Dec 8.

6.

ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis.

Jiang J, Liang X, Zhou X, Huang R, Chu Z, Zhan Q.

Mol Biol Rep. 2012 Jun;39(6):6933-42. doi: 10.1007/s11033-012-1520-4.

PMID:
22302397
7.

Gene expression-based classification of non-small cell lung carcinomas and survival prediction.

Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens JA, Hoogsteden HC, Grosveld F, Philipsen S.

PLoS One. 2010 Apr 22;5(4):e10312. doi: 10.1371/journal.pone.0010312.

8.

Relation between prognosis and expression of metastasis-associated protein 1 in stage I non-small cell lung cancer.

Yu Y, Wang Z, Zhang MY, Liu XY, Zhang H.

Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):166-9. doi: 10.1510/icvts.2010.243741. Epub 2010 Oct 8.

PMID:
20935042
9.

Is gene array testing to be considered routine now?

Paik S.

Breast. 2011 Oct;20 Suppl 3:S87-91. doi: 10.1016/S0960-9776(11)70301-0. Review.

PMID:
22015300
10.

Gene expression profiling of non-small-cell lung cancer.

Lacroix L, Commo F, Soria JC.

Expert Rev Mol Diagn. 2008 Mar;8(2):167-78. doi: 10.1586/14737159.8.2.167. Review.

PMID:
18366303
11.

Gene expression signature with independent prognostic significance in epithelial ovarian cancer.

Spentzos D, Levine DA, Ramoni MF, Joseph M, Gu X, Boyd J, Libermann TA, Cannistra SA.

J Clin Oncol. 2004 Dec 1;22(23):4700-10. Epub 2004 Oct 25. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

PMID:
15505275
12.

Understanding prognostic gene expression signatures in lung cancer.

Zhu CQ, Pintilie M, John T, Strumpf D, Shepherd FA, Der SD, Jurisica I, Tsao MS.

Clin Lung Cancer. 2009 Sep;10(5):331-40. doi: 10.3816/CLC.2009.n.045. Review.

PMID:
19808191
13.

Prognostic gene signatures for non-small-cell lung cancer.

Boutros PC, Lau SK, Pintilie M, Liu N, Shepherd FA, Der SD, Tsao MS, Penn LZ, Jurisica I.

Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2824-8. doi: 10.1073/pnas.0809444106. Epub 2009 Feb 5.

14.

Clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review.

Hornberger J, Alvarado MD, Rebecca C, Gutierrez HR, Yu TM, Gradishar WJ.

J Natl Cancer Inst. 2012 Jul 18;104(14):1068-79. doi: 10.1093/jnci/djs261. Epub 2012 Jul 5. Review.

PMID:
22767204
15.

Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer.

Cox G, Louise Jones J, Andi A, Abrams KR, O'Byrne KJ.

Lung Cancer. 2001 Dec;34(3):417-26.

PMID:
11714539
16.

Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically-treated patients with non-small cell lung cancer.

Pesta M, Kulda V, Fiala O, Safranek J, Topolcan O, Krakorova G, Cerny R, Pesek M.

Anticancer Res. 2012 Nov;32(11):5003-10.

PMID:
23155271
17.

Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer.

Anguiano A, Potti A.

Expert Rev Mol Diagn. 2007 Nov;7(6):837-44. Review.

PMID:
18020912
18.

Gene expression profiles in esophageal adenocarcinoma predict survival after resection.

Pennathur A, Xi L, Litle VR, Gooding WE, Krasinskas A, Landreneau RJ, Godfrey TE, Luketich JD.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):505-12; discussion 512-3. doi: 10.1016/j.jtcvs.2012.10.031.

19.

Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets.

Yao J, Zhao Q, Yuan Y, Zhang L, Liu X, Yung WK, Weinstein JN.

PLoS One. 2012;7(9):e45894. doi: 10.1371/journal.pone.0045894. Epub 2012 Sep 21.

20.

Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.

Grunnet M, Sorensen JB.

Lung Cancer. 2012 May;76(2):138-43. doi: 10.1016/j.lungcan.2011.11.012. Epub 2011 Dec 6. Review.

PMID:
22153832

Supplemental Content

Support Center